Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimark in Pediatric Patients for Contrast-Enhanced MRI
NCT01092754Phase 4Completed
- Sponsor
- Guerbet
- Start
- May 2002
- Primary completion
- Dec 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadoversetamide in liver disease, Central nervous system diseases, sponsored by Guerbet. Started May 2002; status: completed.
02
Drugs
gadoversetamide
03
Conditions
liver diseaseCentral nervous system diseases
Beyond the preview
Go deeper on NCT01092754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092754.